Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mihoko Takami"'
Autor:
Fumio Sugawara, Susumu Kobayashi, Kengo Sakaguchi, Kengo Morohashi, Keisuke Ohta, Satoko Aoki, Senko Tsukuda, Kouji Kuramochi, Yoichi Takakusagi, Mihoko Takami
Publikováno v:
Molecules, Vol 16, Iss 5, Pp 4278-4294 (2011)
Etoposide (VP-16) is an anti-tumor compound that targets topoisomerase II (top II). In this study, we have identified an alternative binding protein of etoposide by screening a library of T7 phage-displayed peptides. After four rounds of selection us
Externí odkaz:
https://doaj.org/article/7fbbc1c93526420daeaa1e983505e713
Autor:
Kengo Sakaguchi, Fumio Sugawara, Keisuke Ohta, Yoichi Takakusagi, Kouji Kuramochi, Satoko Aoki, Kengo Morohashi, Mihoko Takami, Susumu Kobayashi, Senko Tsukuda
Publikováno v:
Molecules
Molecules, Vol 16, Iss 5, Pp 4278-4294 (2011)
Molecules; Volume 16; Issue 5; Pages: 4278-4294
Molecules, Vol 16, Iss 5, Pp 4278-4294 (2011)
Molecules; Volume 16; Issue 5; Pages: 4278-4294
Etoposide (VP-16) is an anti-tumor compound that targets topoisomerase II (top II). In this study, we have identified an alternative binding protein of etoposide by screening a library of T7 phage-displayed peptides. After four rounds of selection us
Autor:
Tetsuro Morimura, Mihoko Takami, Masahiko Ohshige, Hiroshi Kameda, Fumio Sugawara, Hirokazu Takahama, Mio Hashiba
Publikováno v:
The Journal of Antibiotics. 61:291-296
Clarithromycin is a macrolide antibiotic that is widely used in clinical medicine. Macrolide antibiotics such as clarithromycin specifically bind to the 50S subunit of the bacterial ribosome thereby interfering with protein biosynthesis. A selected p
Autor:
Mihoko Takami, Masahiro Amakawa, Tango Handa, Yoshihide Miyake, Yasushi Matsumura, Katsuhiko Konishi, Takahiko Murata
Publikováno v:
Gastroenterology. 140:S-517
Autor:
Yuki Matsumoto, Hiroshi Murata, Mihoko Takami, Satoko Aoki, Kaori Takakusagi, Kengo Sakaguchi, Noriko Ida, Tadashi Nakabayashi, Fumio Sugawara, Keisuke Ohta, Yoichi Takakusagi, Tomoe Kusayanagi
Publikováno v:
MedChemComm. 2:1188
Sulfoquinovosylacylglycerol (SQAG) is a sulfoglycolipid showing anti-angiogenic and radiosensitizing effects for treatment of solid tumors both in vitro and in vivo. Here we elucidated the interaction of SQAG with various growth factors and their cog